U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups

Patent 5976858 Issued on November 2, 1999. Estimated Expiration Date: Icon_subject August 23, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

଱ Amino fluoro ketones
Patent #: 4518528
Issued on: 05/21/1985
Inventor: Rasnick

Cysteine proteinase inhibitor
Patent #: 5037957
Issued on: 08/06/1991
Inventor: Grubb, et al.

Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
Patent #: 5055451
Issued on: 10/08/1991
Inventor: Krantz, et al.

Magnesium fluoromalonates
Patent #: 5101068
Issued on: 03/31/1992
Inventor: Palmer

Information recording medium having high modulation degree
Patent #: 5274623
Issued on: 12/28/1993
Inventor: Usami, et al.

20-position modified pharmaceutically active vitamin D series compounds Patent #: 5585368
Issued on: 12/17/1996
Inventor: Steinmeyer, et al.

Inventors

Assignee

Application

No. 700518 filed on 08/23/1996

US Classes:

435/219, Proteinase435/184, Enzyme inactivation by chemical treatment514/18, 3 or 4 peptide repeating units in known peptide chain514/192 peptide repeating units in known peptide chain

Examiners

Primary: Weber, Jon P.

Attorney, Agent or Firm

Foreign Patent References

  • 04202170 JP. 07/25/1992
  • 04/273897 JP. 09/25/1992
  • 04273896 JP. 09/25/1992
  • 05213990 JP. 08/25/1993
  • 93/14777 WO. 08/25/1993
  • 93/16710 WO. 09/25/1993

International Classes

C12N 009/50
C12N 009/99
A61K 038/00

Abstract

Irreversible cysteine protease inhibitors based upon an alkene bond being conjugated to an electron withdrawing group are disclosed. The inhibitor structure also provides a targeting peptide which is specific for different cysteine proteases. The method of making the inhibitors, and methods of using the inhibitors to inhibit cysteine proteases and for therapy are disclosed.

Other References

  • Reetz et al. (1992) Angew. Chem. Int. Ed. Engl., 31(12), 1626-1629
  • Meng et al. (1991) Tetrahedron Lett., 47(32), 6251-6264
  • Kolter et al. (1992) Angew. Chem. Int. Ed. Engl., 31(10), 1391-1392
  • Smith et al. (1988) J. Med. Chem., 31(7), 1377-1382
  • Barton et al. (1987) Tetrahedron, 43(19), 4297-4308
  • Hagihara et al. (1992) J. Am. Chem. Soc., 114(16), 6570-6571
  • Maryanoff et al. (1991) Proc. Natl. Acad. Sci., USA, 90(17), 8048-8052
  • Rich et al. (1980) J. Med. Chem., 23, 27-33
  • Hanzlik et al. (1984) J. Med. Chem. , 27(6), "Vinylogous Amino Acid Esters: A New Class of Inactivators for Thiol Proteases", pp. 711-712
  • Liu et al. (1992) J. Med. Chem., 35(6), "Structure-Activity Relationships for Inhibition of Papain by Peptide Michael Acceptors", pp. 1067-1075
  • Thompson et al. (1986) J. Med. Chem., 29(1), "Carboxyl-Modified Amino Acids and Peptides as Protease Inhibitors", pp. 104-111
  • Rawlings et al., "Evolutionary Families of Peptidases," J. Biochem., 290:205-218 (1993)
  • Walker et al., "Peptidylmethyl Sulfonium Salts, A New Class of Thiol Protease Inactivators," Protease Inhibitors, p. 1433 (Abstract No. 5975)
  • Fehrentz et al., "An Efficient Synthesis of Optically Active ଱-(t-Butoxycarbonylamino)-aldehydes from ଱-Amino Acids," Communications, pp. 676-678 (1983)
  • Mehdi, "Synthetic and Naturally Occurring Protease Inhibitors Containing an Electrophilic Carbonyl Group," Bioorganic Chemistry, 21:249-259 (1993)
  • Wadsworth et al., "The Utility of Phosphonate Carbanions in Olefin Synthesis," [Contribution from Rohm and Haas Co., Philadlphia 37, Penna.], 83:1733-1738 (1961)
  • Bromme et al., "Novel-N-peptidyl-O-acyl Hydroxamates: Selective Inhibitors of Cysteine Proteinases," Biochimica et Biophysica Acta., 1202:271-276 (1993)
  • Rosenthal et al., "Antimalarial Effects of Peptide Inhibitors of a Plasmodium Falciparum Cysteine Proteinase," J. Clin. Invest., 88:1467-1472 (1991)
  • Rasnick, "Synthesis of Peptide Fluormethyl Ketones and the Inhibition of Human Cathepsin B," Analytical Biochemistry, 149:461-465 (1985)
  • Kirschke et al., "Rapid Inactivation of Cathepsin L by Z-Phe-Phechn12 and Z-Phe-Alachn2," Biochemical and Biophysical Research Communications, 101(2):454-458 (1981)
  • Krantz et al., "Peptidyl (Acyloxy)methyl Ketones and the Quiescent Affinity Label Concept: The Departing Group as a Variable Structural Element in the Design of Inactivators of Cysteine Proteinases," Biochemistry, 30:4678-4687 (1991)
  • Hanada et al., "Isolation and Characterization of E-64, A New Thiol Protease Inhibitor," Agric. Biol. Chem., 42(3):523-528 (1978)
  • Sumiya et al., "Molecular Design of Potent Inhibitor Specific for Cathepsin B Based on the Tertiary Structure Prediction," Chem. Pharm. Bul., 40(2):299-303 (1992)
  • Gour-Salin et al., "Epoxysuccinyl Dipeptides as Selective Inhibitors of Cathepsin B," J. Med. Chem., 36:720-725 (1993)
  • Barrett et al., "Proteinase Inhibitors," Chapter 4, pp. 154-177, in Dingle et al., Research Monographs in Cell and Tissue Physiology, vol. 12, Elsevier (1986)
  • Shaw, "Cysteinyl Proetinases and Their Selective Inactivation," Advances in Enzymology and Related Areas of Molecular Biology, 63:271-347 (1990)
  • Anderson et al., "Nucleophilic an dElectrophilic Mercaptanylations via 2-(Trimethylsilyl) ethanethiol-Derived Reagenst," J. Org. Chem., 53:3125-3127 (1988)
  • Spaltenstein et al., "New Approaches to the Syntheis of trans-ALkene Isosteres of Dipeptides," J. Org. Chem., 52:3759-3766 (1987)
  • McIlwain, "Amino-Suphonic Acid Analogues of Natural Amino-Carboxylic Acids," Department of Bacterial Chemistry (Medical Research Counsil), Bland Sutton Institute of Pathology and the Courtauld Institute of Biochemistry, pp. 75-77 (1941)
  • Engberts et al., "The Mannich Condensation of Sulfinic Acids, Aldehyde, and Ethyl Carbamate," Recueil, 84:942-950 (1965)
  • Esser, "Cysteine Proteinase Inhibitors Decrease Articular Cartilage and Bone Destruction in Chronic Inflammatory Arthritis," Arthritis & Rheumatism, 37(2):236-247 (1994)
  • Sebti et al., "Metabolic Inactivation: A Mechanism of Human Tumor Resistance to Bleomycin," Cancer Res., pp. 227-232 (Jan. 1991)
  • Brillon et al., J. Org. Chem., 57:1838-1842 (1992)
  • Aoyagi et al., "Structures and Activities of Protease Inhibitors of Microbial Origin," Chemical Abstracts, 85:145, Abstract No. 1676 (1975)
  • Morgan et al., "Synthesis and Pharmacology of Dipeptides Related to des [Gly3 ] Enkaphalin: Modification of the C-Terminal Amide," Chemical Abstracts, 106:650, Abstract No. 85020 (1985)
  • Boden et al., "Rationally Designed `Dipeptoid` Analogues of Cholecystokinin (CCK): C-Terminal Structure-Activity Relationships of ଱-methyl Tryptophan Derivatives," Eur. J. Med. Chem., 28:47-61 (1993)
  • Liu et al., "The Contribution of Intermolecular Hydrogen Bonding to the Kinetic Specificity of Papain," Biochim. Biophys. Acta., 1158(3):264-272 (1993)
  • Liu et al., "Effects of Homologetaion and Ligand Reactivity on the Apparent Kinetic Specificity of Papain," Biochim. Biophys. Acta., 1250(3):43-48 (1995
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?